Gestational diabetes screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
Regardless of fasting status of mother, 50 gram glucose is loaded and 1 hour later, plasma glucose level should be measured. Measures greater than 130 mg/dL are considered positive.
Regardless of fasting status of mother, 50 gram glucose is loaded and 1 hour later, plasma glucose level should be measured. Measures greater than 130 mg/dL are considered positive.
Considering 130 mg/dl threshold has 88% to 99% sensitivity and 66% to 77% specificity.<ref name="pmid23712349">{{cite journal |vauthors=Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM |title=Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force |journal=Ann. Intern. Med. |volume=159 |issue=2 |pages=115–22 |year=2013 |pmid=23712349 |doi=10.7326/0003-4819-159-2-201307160-00657 |url=}}</ref>
Considering 130 mg/dl threshold has 88% to 99% sensitivity and 66% to 77% specificity.<ref name="pmid23712349">{{cite journal |vauthors=Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM |title=Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force |journal=Ann. Intern. Med. |volume=159 |issue=2 |pages=115–22 |year=2013 |pmid=23712349 |doi=10.7326/0003-4819-159-2-201307160-00657 |url=}}</ref>
*Next step is to confirm the diagnosis by performing a 100 gram 3 hour Glucose Test.
== 2016 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)<ref name="pmid26696680">{{cite journal |vauthors= |title=Standards of Medical Care in Diabetes-2016: Summary of Revisions |journal=Diabetes Care |volume=39 Suppl 1 |issue= |pages=S4–5 |year=2016 |pmid=26696680 |doi=10.2337/dc16-S003 |url=}}</ref>==
== 2016 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)<ref name="pmid26696680">{{cite journal |vauthors= |title=Standards of Medical Care in Diabetes-2016: Summary of Revisions |journal=Diabetes Care |volume=39 Suppl 1 |issue= |pages=S4–5 |year=2016 |pmid=26696680 |doi=10.2337/dc16-S003 |url=}}</ref>==


===Screening for Gestational Diabetes (GDM)===
===Screening for Gestational Diabetes (GDM)===
{|class="wikitable"
{|class="wikitable"
| bgcolor="Seashell"|<nowiki>"</nowiki>'''1.''' Test for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: B]])''<nowiki>"</nowiki>
| bgcolor="Seashell"|<nowiki>"</nowiki>'''1.''' Test for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: B]])''<nowiki>"</nowiki>

Revision as of 19:30, 28 November 2016

Diabetes mellitus main page

Gestational diabetes Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gestational Diabetes from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History and Prognosis

Complications

Maternal
Fetal and Neonatal

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Dietary Therapy

Medical Therapy

Primary Prevention

Secondary Prevention

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gestational diabetes screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gestational diabetes screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gestational diabetes screening

CDC on Gestational diabetes screening

Gestational diabetes screening in the news

Blogs on Gestational diabetes screening

Directions to Hospitals Treating Gestational diabetes

Risk calculators and risk factors for Gestational diabetes screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]


Overview

Screening

Screening can be performed during the first prenatal visit especially, if mother has risk factors for GDM. If the result is negative or test was not done during prenatal care, 24-28 weeks is the best time for screening mothers.[1][2]

50 gram Glucose Test

Regardless of fasting status of mother, 50 gram glucose is loaded and 1 hour later, plasma glucose level should be measured. Measures greater than 130 mg/dL are considered positive. Considering 130 mg/dl threshold has 88% to 99% sensitivity and 66% to 77% specificity.[3]

  • Next step is to confirm the diagnosis by performing a 100 gram 3 hour Glucose Test.

2016 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)[4]

Screening for Gestational Diabetes (GDM)

"1. Test for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. (Level of Evidence: B)"
"2. Test for gestational diabetes mellitus at 24–28 weeks of gestation in pregnant women not previously known to have diabetes. (Level of Evidence: A)"
"3. Screen women with gestational diabetes mellitus for persistent diabetes at 6–12 weeks postpartum, using the oral glucose tolerance test and clinically appropriate nonpregnancy diagnostic criteria (Level of Evidence: E)"
"4. Women with a history of gestational diabetes mellitus should have lifelong screening for the development of diabetes or prediabetes at least every 3 years. (Level of Evidence: B)"
"5. Women with a history of gestational diabetes mellitus found to have prediabetes should receive lifestyle interventions or metformin to prevent diabetes. (Level of Evidence: A)"

References

  1. "2. Classification and Diagnosis of Diabetes". Diabetes Care. 39 Suppl 1: S13–22. 2016. doi:10.2337/dc16-S005. PMID 26696675.
  2. Moyer VA (2014). "Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement". Ann. Intern. Med. 160 (6): 414–20. doi:10.7326/M13-2905. PMID 24424622.
  3. Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM (2013). "Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force". Ann. Intern. Med. 159 (2): 115–22. doi:10.7326/0003-4819-159-2-201307160-00657. PMID 23712349.
  4. "Standards of Medical Care in Diabetes-2016: Summary of Revisions". Diabetes Care. 39 Suppl 1: S4–5. 2016. doi:10.2337/dc16-S003. PMID 26696680.

Template:WH Template:WS